Phosphodiesterase III Inhibition Increases cAMP Levels and Augments the Infarct Size Limiting Effect of a DPP-4 Inhibitor in Mice with Type-2 Diabetes Mellitus
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphodiesterase III Inhibition Increases cAMP Levels and Augments the Infarct Size Limiting Effect of a DPP-4 Inhibitor in Mice with Type-2 Diabetes Mellitus
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 26, Issue 6, Pages 445-456
Publisher
Springer Nature
Online
2012-08-30
DOI
10.1007/s10557-012-6409-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphorylation of 5-Lipoxygenase at Ser523 by Protein Kinase A Determines Whether Pioglitazone and Atorvastatin Induce Proinflammatory Leukotriene B4 or Anti-Inflammatory 15-Epi-Lipoxin A4 Production
- (2014) Y. Ye et al. JOURNAL OF IMMUNOLOGY
- Regulation of phosphatase and tensin homolog on chromosome 10 in response to hypoxia
- (2012) Jinqiao Qian et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiovascular effects of the DPP-4 inhibitors
- (2012) Tessey Jose et al. Diabetes & Vascular Disease Research
- Cardioprotective effects of incretin during ischaemia-reperfusion
- (2012) Kroekkiat Chinda et al. Diabetes & Vascular Disease Research
- Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia–reperfusion injury
- (2012) Kroekkiat Chinda et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- INTRAVASCULAR ULTRASOUND LUMEN AREA PARAMETERS FOR ASSESSMENT OF PHYSIOLOGICAL ISCHEMIA BY FRACTIONAL FLOW RESERVE IN INTERMEDIATE CORONARY ARTERY STENOSIS
- (2012) Rebecca Torguson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
- (2011) Yumei Ye et al. BASIC RESEARCH IN CARDIOLOGY
- CREB Is a Novel Nuclear Target of PTEN Phosphatase
- (2011) T. Gu et al. CANCER RESEARCH
- Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
- (2011) Meimei Yin et al. Cardiovascular Diabetology
- Aliskiren and Valsartan Reduce Myocardial AT1 Receptor Expression and Limit Myocardial Infarct Size in Diabetic Mice
- (2011) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
- (2011) Oscar Vadas et al. Science Signaling
- Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
- (2011) Jae-Geun Lee et al. Diabetes & Metabolism Journal
- Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction
- (2010) Kyle T. Keyes et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Resolvin E1 protects the rat heart against reperfusion injury
- (2010) K. T. Keyes et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA
- (2010) Yumei Ye et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic Rats
- (2010) Barbara Huisamen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor
- (2010) Kiwon Ban et al. ENDOCRINOLOGY
- Cross-Talk Between PKA and Akt Protects Endothelial Cells From Apoptosis in the Late Ischemic Preconditioning
- (2009) Alessandro Bellis et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cardiac regulation by phosphoinositide 3-kinases and PTEN
- (2009) G. Y. Oudit et al. CARDIOVASCULAR RESEARCH
- Cilostazol Ameliorates Metabolic Abnormalities with Suppression of Proinflammatory Markers in a db/db Mouse Model of Type 2 Diabetes via Activation of Peroxisome Proliferator-Activated Receptor Transcription
- (2009) S. Y. Park et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion Injury
- (2009) Leo Timmers et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Phosphorylation keeps PTEN phosphatase closed for business
- (2009) A. H. Ross et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
- (2009) Roger Yazbeck et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Vascular and Biochemical Effects of Cilostazol in Diabetic Patients With Peripheral Arterial Disease
- (2009) Mark E. O'Donnell et al. Vascular and Endovascular Surgery
- Cilostazol increases 3T3-L1 preadipocyte differentiation with improved glucose uptake associated with activation of peroxisome proliferator-activated receptor-γ transcription
- (2008) So Youn Park et al. ATHEROSCLEROSIS
- CREB Activation and Ischaemic Preconditioning
- (2008) E. Marais et al. CARDIOVASCULAR DRUGS AND THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now